Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Myriad Genetics Inc (MYGN)
since 2005 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Myriad Genetics Inc.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 899923.
Total stock buying since 2005: $951,678.
Total stock sales since 2005: $299,133,778.
Total stock option exercises since 2005: $124,356,444.
Table 3. Detailed insider trading at Myriad Genetics Inc (MYGN) , Part 4
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2009-05-13 | Henderson John T (Director) | Buy | 300 | 32.73 | 9,819 |
| 2009-05-11 | Skolnick Mark H (Chief Scientific Officer) | Sale | 6,992 | 32.50 | 227,240 |
| 2009-05-11 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 6,992 | 2.39 | 16,710 |
| 2009-05-08 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Ex | 29,178 | 10.28 | 299,949 |
| 2009-05-08 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 5,000 | 10.28 | 51,400 |
| 2009-05-08 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Ex | 2,636 | 12.53 | 33,031 |
| 2009-05-08 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 17,742 | 5.82 | 103,258 |
| 2009-05-08 | Skolnick Mark H (Chief Scientific Officer) | Sale | 4,601 | 32.59 | 149,946 |
| 2009-05-08 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 4,601 | 2.39 | 10,996 |
| 2009-05-07 | Belle Gerald P. (Director) | Buy | 1,000 | 32.50 | 32,500 |
| 2009-05-07 | Skolnick Mark H (Chief Scientific Officer) | Sale | 10,399 | 32.16 | 334,463 |
| 2009-05-07 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 10,399 | 2.39 | 24,853 |
| 2009-04-06 | Capone Mark Christopher (Chief Operating Officer, MGL) | Sale | 36,000 | 43.09 | 1,551,060 |
| 2009-04-06 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Ex | 36,000 | 18.00 | 647,892 |
| 2009-03-27 | Laslie W Wayne (Chief Operating Officer, MPI) | Sale | 24,000 | 44.96 | 1,079,040 |
| 2009-03-27 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Ex | 24,000 | 9.75 | 234,000 |
| 2009-03-26 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 20,000 | 46.74 | 934,800 |
| 2009-03-26 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 20,000 | 8.48 | 169,700 |
| 2009-03-04 | Skolnick Mark H (Chief Scientific Officer) | Sale | 2,000 | 79.00 | 158,000 |
| 2009-03-04 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 2,000 | 4.78 | 9,562 |
| 2009-03-02 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 2,500 | 20.56 | 51,400 |
| 2009-02-27 | Skolnick Mark H (Chief Scientific Officer) | Sale | 9,000 | 80.36 | 723,240 |
| 2009-02-27 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 9,000 | 4.78 | 43,029 |
| 2009-02-23 | Evans James S (Chief Financial Officer) | Option Ex | 7,920 | 5.56 | 44,051 |
| 2009-02-23 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Ex | 7,227 | 15.28 | 110,428 |
| 2009-02-23 | Meldrum Peter D (President & C.E.O.) | Option Ex | 4,863 | 20.56 | 99,983 |
| 2009-02-09 | Capone Mark Christopher (Chief Operating Officer, MGL) | Sale | 21,893 | 85.40 | 1,869,618 |
| 2009-02-09 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Ex | 15,812 | 30.00 | 474,360 |
| 2009-02-06 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 10,000 | 84.31 | 843,080 |
| 2009-02-06 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 10,000 | 21.34 | 213,400 |
| 2009-02-05 | Langer Dennis (Director) | Sale | 15,000 | 82.72 | 1,240,725 |
| 2009-02-05 | Langer Dennis (Director) | Option Ex | 15,000 | 25.73 | 386,025 |
| 2009-02-05 | Henderson John T (Director) | Sale | 10,000 | 82.46 | 824,580 |
| 2009-02-05 | Henderson John T (Director) | Option Ex | 10,000 | 17.23 | 172,300 |
| 2009-02-05 | Meldrum Peter D (President & C.E.O.) | Sale | 15,000 | 83.14 | 1,247,130 |
| 2009-02-05 | Meldrum Peter D (President & C.E.O.) | Option Ex | 15,000 | 25.06 | 375,930 |
| 2009-02-04 | Marsh Richard M (V.P., General Counsel) | Sale | 237 | 85.00 | 20,145 |
| 2009-02-04 | Marsh Richard M (V.P., General Counsel) | Option Ex | 237 | 17.86 | 4,232 |
| 2009-02-03 | Harrison Robert Gardner (Chief Information Officer) | Sale | 4,000 | 83.33 | 333,332 |
| 2009-02-03 | Harrison Robert Gardner (Chief Information Officer) | Option Ex | 4,000 | 14.01 | 56,040 |
| 2009-02-03 | Evans James S (Chief Financial Officer) | Sale | 10,964 | 79.68 | 873,611 |
| 2009-02-03 | Evans James S (Chief Financial Officer) | Option Ex | 10,964 | 16.97 | 186,059 |
| 2009-02-03 | Marsh Richard M (V.P., General Counsel) | Sale | 10,763 | 85.00 | 914,855 |
| 2009-02-03 | Marsh Richard M (V.P., General Counsel) | Option Ex | 10,763 | 17.86 | 192,227 |
| 2009-02-03 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 82.06 | 820,610 |
| 2009-02-02 | Marsh Richard M (V.P., General Counsel) | Option Ex | 4,863 | 20.56 | 99,983 |
| 2009-01-30 | Marsh Richard M (V.P., General Counsel) | Sale | 9,804 | 75.03 | 735,603 |
| 2009-01-30 | Marsh Richard M (V.P., General Counsel) | Option Ex | 9,804 | 17.86 | 175,099 |
| 2009-01-29 | Marsh Richard M (V.P., General Counsel) | Sale | 1,800 | 75.06 | 135,115 |
| 2009-01-29 | Marsh Richard M (V.P., General Counsel) | Option Ex | 1,800 | 17.86 | 32,148 |
| 2009-01-29 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Ex | 14,000 | 4.78 | 66,934 |
| 2009-01-28 | Critchfield Gregory C (President Myriad Genetic Labs) | Sale | 20,000 | 74.50 | 1,490,000 |
| 2009-01-28 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Ex | 20,000 | 16.64 | 332,800 |
| 2009-01-06 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 5,000 | 20.56 | 102,800 |
| 2008-12-18 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 10,000 | 67.00 | 670,000 |
| 2008-12-18 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 10,000 | 18.77 | 187,650 |
| 2008-12-11 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 20,000 | 60.60 | 1,212,060 |
| 2008-12-11 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 20,000 | 4.78 | 95,620 |
| 2008-12-09 | Wilson Linda S (Director) | Sale | 16,000 | 63.91 | 1,022,608 |
| 2008-12-09 | Wilson Linda S (Director) | Option Ex | 16,000 | 34.57 | 553,120 |
| 2008-11-21 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Ex | 5,128 | 19.50 | 99,996 |
| 2008-11-10 | Skolnick Mark H (Chief Scientific Officer) | Sale | 10,000 | 71.15 | 711,500 |
| 2008-11-10 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 10,000 | 4.78 | 47,810 |
| 2008-11-04 | Laslie W Wayne (Chief Operating Officer, MPI) | Sale | 12,000 | 70.00 | 840,000 |
| 2008-11-04 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Ex | 12,000 | 19.50 | 234,000 |
| 2008-11-04 | Meldrum Peter D (President & C.E.O.) | Sale | 10,000 | 70.26 | 702,630 |
| 2008-09-29 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 21,068 | 5.12 | 107,973 |
| 2008-09-25 | Evans James S (Chief Financial Officer) | Sale | 6,669 | 69.00 | 460,161 |
| 2008-09-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 15,000 | 68.54 | 1,028,130 |
| 2008-09-23 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 10,000 | 5.12 | 51,250 |
| 2008-09-19 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 992 | 66.00 | 65,472 |
| 2008-09-19 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 992 | 5.12 | 5,084 |
| 2008-09-19 | Wilson Linda S (Director) | Sale | 12,500 | 65.81 | 822,575 |
| 2008-09-19 | Wilson Linda S (Director) | Option Ex | 12,500 | 28.02 | 350,275 |
| 2008-09-18 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 10,000 | 5.12 | 51,250 |
| 2008-09-17 | Critchfield Gregory C (President Myriad Genetic Labs) | Sale | 32,380 | 66.08 | 2,139,638 |
| 2008-09-17 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Ex | 32,380 | 12.54 | 406,045 |
| 2008-09-17 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 500 | 66.49 | 33,245 |
| 2008-09-17 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 500 | 5.12 | 2,562 |
| 2008-09-16 | Skolnick Mark H (Chief Scientific Officer) | Sale | 19,500 | 66.00 | 1,287,000 |
| 2008-09-09 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Ex | 3,000 | 15.28 | 45,840 |
| 2008-09-08 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 28,447 | 64.03 | 1,821,603 |
| 2008-09-08 | Hockett William A Iii (V. P. of Corp Communications) | Option Ex | 28,447 | 28.63 | 814,380 |
| 2008-09-05 | Langer Dennis (Director) | Sale | 4,280 | 63.50 | 271,780 |
| 2008-09-05 | Langer Dennis (Director) | Option Ex | 4,280 | 21.49 | 91,977 |
| 2008-09-05 | Gilbert Walter Phd (Director) | Sale | 10,000 | 63.31 | 633,100 |
| 2008-09-05 | Gilbert Walter Phd (Director) | Option Ex | 10,000 | 25.73 | 257,350 |
| 2008-09-04 | Langer Dennis (Director) | Sale | 5,720 | 65.73 | 375,969 |
| 2008-09-04 | Langer Dennis (Director) | Option Ex | 5,720 | 21.49 | 122,922 |
| 2008-09-04 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 6,714 | 17.68 | 118,737 |
| 2008-09-03 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 20,000 | 67.07 | 1,341,480 |
| 2008-09-03 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 20,000 | 16.64 | 332,800 |
| 2008-09-03 | Skolnick Mark H (Chief Scientific Officer) | Sale | 500 | 68.51 | 34,257 |
| 2008-09-02 | Meldrum Peter D (President & C.E.O.) | Option Ex | 9,727 | 28.16 | 273,912 |
| 2008-08-29 | Capone Mark Christopher (Chief Operating Officer, MGL) | Sale | 18,000 | 67.93 | 1,222,812 |
| 2008-08-29 | Capone Mark Christopher (Chief Operating Officer, MGL) | Option Ex | 18,000 | 18.90 | 340,164 |
| 2008-08-29 | Marsh Richard M (V.P., General Counsel) | Sale | 11,198 | 68.26 | 764,353 |
| 2008-08-29 | Marsh Richard M (V.P., General Counsel) | Option Ex | 11,198 | 17.86 | 199,996 |
| 2008-08-29 | Meldrum Peter D (President & C.E.O.) | Sale | 15,998 | 68.07 | 1,088,919 |
| 2008-08-29 | Meldrum Peter D (President & C.E.O.) | Option Ex | 15,998 | 4.78 | 76,486 |
| 2008-08-27 | Harrison Robert Gardner (Chief Information Officer) | Sale | 4,085 | 65.90 | 269,201 |
| 2008-08-27 | Harrison Robert Gardner (Chief Information Officer) | Option Ex | 4,085 | 11.09 | 45,302 |
| 2008-08-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Sale | 27,464 | 65.03 | 1,785,928 |
| 2008-08-25 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 27,464 | 5.12 | 140,753 |
| 2008-05-19 | Wilson Linda S (Director) | Option Ex | 50 | 29.98 | 1,499 |
| 2008-04-14 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 3,500 | 14.81 | 51,835 |
| 2008-03-20 | Skolnick Mark H (Chief Scientific Officer) | Sale | 20,000 | 35.12 | 701,415 |
| 2008-03-20 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 20,000 | 9.31 | 186,239 |
| 2008-03-10 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 3,000 | 14.81 | 44,430 |
| 2008-03-10 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 10,000 | 5.12 | 51,250 |
| 2008-03-10 | Meldrum Peter D (President & C.E.O.) | Option Ex | 2,462 | 25.06 | 61,702 |
| 2008-03-04 | Hockett William A Iii (V. P. of Corp Communications) | Option Ex | 8,693 | 11.64 | 101,186 |
| 2008-02-12 | Marsh Richard M (V.P., General Counsel) | Option Ex | 6,526 | 20.56 | 134,174 |
| 2008-02-07 | Skolnick Mark H (Chief Scientific Officer) | Sale | 25,000 | 39.21 | 977,390 |
| 2008-02-07 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 25,000 | 9.31 | 232,799 |
| 2008-02-01 | Evans James S (Chief Financial Officer) | Option Ex | 6,000 | 5.12 | 30,750 |
| 2008-01-30 | Skolnick Mark H (Chief Scientific Officer) | Option Ex | 25,000 | 9.31 | 232,799 |
| 2008-01-25 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Ex | 18,644 | 7.03 | 131,084 |
| 2007-12-20 | Langer Dennis (Director) | Sale | 20,000 | 47.62 | 952,380 |
| 2007-12-20 | Langer Dennis (Director) | Option Ex | 20,000 | 19.09 | 381,740 |
| 2007-12-20 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Ex | 4,900 | 7.03 | 34,451 |
| 2007-12-19 | Langer Dennis (Director) | Sale | 10,000 | 47.52 | 475,150 |
| 2007-12-19 | Langer Dennis (Director) | Option Ex | 10,000 | 17.23 | 172,300 |
| 2007-12-07 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 2,692 | 50.71 | 136,319 |
| 2007-12-06 | Skolnick Mark H (Chief Scientific Officer) | Sale | 27,000 | 50.45 | 1,362,150 |
| 2007-12-04 | Laslie W Wayne (Chief Operating Officer, MPI) | Sale | 1,122 | 48.30 | 54,192 |
| 2007-11-30 | Hobden Adrian N (Pres. Myriad Pharmaceuticals) | Option Ex | 5,000 | 5.12 | 25,625 |
| 2007-11-30 | Wilson Linda S (Director) | Sale | 25,000 | 48.20 | 1,205,075 |
| 2007-11-30 | Wilson Linda S (Director) | Option Ex | 23,900 | 10.76 | 257,187 |
| 2007-11-21 | Marsh Richard M (V.P., General Counsel) | Option Ex | 1,600 | 20.56 | 32,896 |
| 2007-11-05 | Gilbert Walter Phd (Director) | Sale | 35,000 | 52.82 | 1,847,254 |
| 2007-11-05 | Gilbert Walter Phd (Director) | Option Ex | 35,000 | 18.09 | 638,881 |
| 2007-10-22 | Marsh Richard M (V.P., General Counsel) | Option Ex | 1,600 | 20.56 | 32,896 |
| 2007-10-15 | Evans James S (V.P. Finance) | Sale | 6,555 | 54.93 | 360,079 |
| 2007-10-15 | Hockett William A Iii (V. P. of Corp Communications) | Sale | 4,886 | 55.21 | 269,129 |
| 2007-10-15 | Moyes Jay M (Chief Financial Officer) | Sale | 39,520 | 54.97 | 2,177,915 |
| 2007-10-15 | Moyes Jay M (Chief Financial Officer) | Option Ex | 39,520 | 12.54 | 495,578 |
| 2007-10-15 | Meldrum Peter D (President & C.E.O.) | Sale | 20,000 | 55.30 | 1,105,920 |
| 2007-10-11 | Laslie W Wayne (Chief Operating Officer, MPI) | Sale | 10,000 | 57.26 | 572,630 |
| 2007-10-11 | Laslie W Wayne (Chief Operating Officer, MPI) | Option Ex | 10,000 | 19.50 | 195,000 |
| 2007-10-05 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 10,000 | 86.70 | 866,979 |
| 2007-10-05 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 10,000 | 13.45 | 134,480 |
| 2007-09-27 | Lanchbury Jerry S (Executive V.P. - Research) | Sale | 10,036 | 52.01 | 521,922 |
| 2007-09-27 | Lanchbury Jerry S (Executive V.P. - Research) | Option Ex | 10,036 | 14.81 | 148,633 |
| 2007-09-26 | Marsh Richard M (V.P., General Counsel) | Sale | 6,323 | 50.00 | 316,150 |
| 2007-09-26 | Marsh Richard M (V.P., General Counsel) | Option Ex | 6,323 | 12.54 | 79,290 |
| 2007-09-26 | Critchfield Gregory C (President Myriad Genetic Labs) | Sale | 9,342 | 50.00 | 467,100 |
| 2007-09-26 | Critchfield Gregory C (President Myriad Genetic Labs) | Option Ex | 9,342 | 4.78 | 44,664 |
| 2007-09-25 | Marsh Richard M (V.P., General Counsel) | Sale | 6,177 | 50.00 | 308,850 |
| 2007-09-25 | Marsh Richard M (V.P., General Counsel) | Option Ex | 6,177 | 12.54 | 77,459 |
Insider trading activities including stock purchases, stock sales, and option exercises
of MYGN listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Myriad Genetics Inc (symbol MYGN,
CIK number 899923) see
the Securities and Exchange Commission (SEC) website.